Business
Coronavirus vaccine: Oxford, AstraZeneca resume trial after patient’s serious side-effect – PerthNow
Days after a vaccine trial was suspended following a reported side-effect in a UK patient, Oxford University has announced the study will resume.
Oxford University has announced it is resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a UK patient.
In a statement on Saturday, the university confirmed the restart across all of its UK clinical trial sites after regulators gave the go-ahead following the pause on Sunday.
The independent review process has concluded and following the recommendations of…
-
Noosa News20 hours agoYoung voices shape Sunshine Coast’s future
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News19 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference
-
General16 hours agoMyanmar earthquake rescue efforts wind down as death toll hits 3,600